AzTrials
AzTrials

Borderline Personality DisorderNCT07119541

Testing an Alliance-Focused Dialectical Behaviour Therapy Training for Borderline Personality Disorder

A study testing Alliance-Focused Dialectical Behavior Therapy plus Deliberate Practice and Alliance-Focused Dialectical Behavior Therapy plus Reflective Practice in people with Borderline Personality Disorder and Emotion Dysregulation, run by York University at 1 site in Canada.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The study evaluates the feasibility, acceptability, and effect sizes of two alliance-focused dialectical behavior therapy (DBT) training interventions to improve therapists' abilities to recognize and respond to alliance ruptures with clients with borderline personality disorder (BPD). Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Alliance-Focused Dialectical Behavior Therapy plus Deliberate Practice and Alliance-Focused Dialectical Behavior Therapy plus Reflective Practice
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteCanada
Study dates
1 Aug 2025to 30 Sep 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Participants must be over the age of 18
  • Participants must be regulated health professionals in Canada who are authorized to deliver psychotherapy as part of their scope of practice, or a students in training under the supervision of a regulated health professional in Canada authorized to deliver psychotherapy as part of their scope of practice.
  • Participants must currently be providing psychotherapy
  • Participants must have access to reliable internet service
  • Participants must indicate that they are available to attend the training intervention times provided
  • Participants must agree to participate in the 4 weekly training intervention
  • Participants must state willingness to comply with study procedures (i.e., to complete pre- and post-intervention research evaluations, and between training homework exercises.

Who cannot join

  • None

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • York University

    Toronto, Ontario, M3J1P3

Other trials in Canada

About this study

Official title: A Pilot Randomized Controlled Trial Evaluating an Alliance-Focused Dialectical Behaviour Therapy Training Intervention for Borderline Personality Disorder

The study evaluates the feasibility, acceptability, and effect sizes of two alliance-focused dialectical behavior therapy (DBT) training interventions to improve therapists' abilities to recognize and respond to alliance ruptures with clients with borderline personality disorder (BPD). Participants will be randomly assigned to receive either a 4-week training as usual (TAU), which include didactic training plus reflective practice (i.e., thinking about past actions to gain insight for future actions) or a 4-week didactic training plus deliberate practice training (i.e., setting individualized training goals, skills coaching, and opportunities for repeated practice with expert feedback). A pre-post design will be used to assess effect sizes for change in participants' abilities to recognize and respond to alliance ruptures. Therapist characteristics will be assessed to determine moderating effects on training outcome. Feasibility and acceptability of the training intervention will be assessed following the trainings.

Read the detailed description

Borderline personality disorder is a severe psychological disorder characterized by a pattern of emotional dysregulation, interpersonal difficulties, and impulsivity. The therapeutic alliance is the cornerstone of effective psychotherapy with clients with BPD and is positively associated with treatment retention and clinical improvement. However, the therapeutic alliance in BPD treatments can be difficult to form and maintain. BPD symptoms such as emotional instability, heightened emotional reactivity, greater susceptibility to negative emotions, and interpersonal sensitivity can impact the establishment of a strong therapeutic alliance. Additionally, when clients are emotionally dysregulated or presenting with high-risk behaviors, therapists are especially vulnerable to becoming reactive and engaging in therapy-interfering behaviors that can elicit or exacerbate alliance ruptures (i.e., tension, strain, or breakdown in the therapeutic alliance). Research suggests that therapists' abilities to effectively repair alliance ruptures when they occur is critical for positive clinical outcomes in BPD treatments.

Despite the importance of alliance rupture responsiveness in BPD treatments, many of the current methods employed in psychotherapy training do not adequately develop these therapeutic skills. Psychotherapy training typically focuses on the therapeutic relationship in an unstructured, non-systematic way, using instructional or supervision-based methods despite evidence that suggests this type of passive learning is ineffective for skill development. Recent advancements in psychotherapy training have begun to focus on improving therapists' skills in navigating alliance rupture and repair, however these trainings are often time intensive and do not sufficiently target the unique client needs and therapist challenges that emerge in BPD treatments.

The primary aim of this pilot randomized controlled trial is to evaluate the feasibility, acceptability, and effect sizes of two alliance-focused DBT training interventions to improve therapists' abilities to recognize and respond to alliance ruptures with BPD clients. Additionally, we will examine whether specific therapist characteristics moderate the impact of training. Up to eighty psychotherapists will be randomly assigned to receive either a 4-week training as usual, which includes alliance-focused training plus reflective practice or a 4-week alliance-focused training plus deliberate practice training. Both trainings include the same content but employ different training methods (i.e., deliberate practice versus reflective practice). Change in skill acquisition related to recognizing and responding to alliance ruptures will be assessed based on a set of performance tasks (interpersonal facilitative skills, process recognition, emotion recognition). Therapist characteristics of emotion regulation, empathy, emotional reactivity, and humility will be assessed by self-report to determine change in emotion regulation, humility, interpersonal reactivity, and empathy, and the moderating effects of these characteristics on training outcome. Finally, participants will be asked about the feasibility and acceptability of the training interventions.

Being tested
Alliance-Focused Dialectical Behavior Therapy plus Deliberate Practice, Alliance-Focused Dialectical Behavior Therapy plus Reflective Practice
Keywords
Dialectical Behavior Therapy, Therapeutic Alliance, Alliance Rupture and Repair, Alliance-Focused Training, Deliberate Practice
Medical subject headings
Borderline Personality Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Alliance-Focused Dialectical Behavior Therapy plus Deliberate PracticeBehavioural

    The alliance-focused DBT training plus deliberate practice is a 4-session weekly intervention delivered to therapists working with individuals with borderline personality disorder or emotion dysregulation. This training intervention involves a didactic component, video analysis, and case-based learning. Deliberate practice methods (e.g., setting individualized training goals, skills coaching, feedback, and opportunities for repeated practice) will be integrated both within and between training sessions.

  • Alliance-Focused Dialectical Behavior Therapy plus Reflective PracticeBehavioural

    The alliance-focused DBT training plus reflective practice is a 4-session weekly intervention delivered to therapists working with individuals with borderline personality disorder or emotion dysregulation. Trainings will involve a didactic component, video analysis, and case-based learning. Reflective practice methods (i.e., thinking about past experiences to gain insight for future actions) will be integrated both within and between training sessions.

Study groups in NCT07119541
Study groupRoleWhat they receive
Alliance-Focused DBT Training plus Deliberate PracticeExperimentalImmediately receives 4 sessions of a psychotherapy training intervention to improve ability to recognize and respond to alliance ruptures in treatments with clients with borderline personality disorder.
Receives: Behavioral: Alliance-Focused Dialectical Behavior Therapy plus Deliberate Practice
Alliance-Focused Training plus Reflective Practice (Training as Usual)Active comparatorImmediately receives 4 sessions of a psychotherapy training intervention to improve ability to recognize and respond to alliance ruptures in treatments with clients with borderline personality disorder.
Receives: Behavioral: Alliance-Focused Dialectical Behavior Therapy plus Reflective Practice

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Facilitative Interpersonal Skills Task (FIS)

    An 8-item video vignette task used to assess ability to respond effectively to challenging client interactions in therapy. Scores range from 56 to 280, with higher scores reflecting higher levels of facilitative interpersonal skills.

    Measured: Administered at baseline (pre-intervention) and at 4 weeks (post-intervention).

Secondary outcomes (7)
  1. Process Recognition Task (PRT)

    A 12-item video vignette task used to assess ability to accurately detect alliance ruptures. Scores range from 0-12, with higher scores reflecting greater accuracy of rupture detection.

    Measured: Administered at baseline (pre-intervention) and at 4 weeks (post-intervention).

  2. Jerusalem Facial Expressions of Emotion Task (JeFEE) - Short Version

    A 28-item video vignette task used to assess ability to accurately identify emotional expression. Scores range from 0 to 28, with higher scores reflecting greater accuracy of emotion recognition.

    Measured: Administered at baseline (pre-intervention) and at 4 weeks (post-intervention).

  3. Comprehensive Intellectual Humility Scale (CIHS)

    A 22-item self-report measure used to assess intellectual humility. Scores range from 22-110, with higher score indicating greater intellectual humility.

    Measured: Administered at baseline (pre-intervention) and at 4 weeks (post-intervention).

  4. Interpersonal Reactivity Index (IRI)

    A 28-item self-report measure that assesses empathy. Scores range from 28 to 140, with higher scores reflecting greater empathy.

    Measured: Administered at baseline (pre-intervention) and at 4 weeks (post-intervention).

  5. Emotional Reactivity Scale (ERS)

    A 21-item self-report measure that assesses emotional sensitivity, intensity, and persistence. Scores range from 0 to 84, with higher scores reflecting greater emotional reactivity

    Measured: Administered at baseline (pre-intervention) and at 4 weeks (post-intervention).

  6. Difficulties in Emotion Regulation Scale (DERS)

    A 36-item self-report measure that assesses difficulties with emotion regulation. Scores range from 36 to 180, with higher scores reflecting greater difficulties in regulating emotions.

    Measured: Administered at baseline (pre-intervention) and at 4 weeks (post-intervention).

  7. Acceptability, Feasibility, and Appropriateness Scale (AFAS)

    Acceptability and appropriateness will be assessed based on a post-training session satisfaction survey developed for this study. Participants will rate 5 items on a 5-point Likert scale from 1 ("Strongly Disagree") to 5 ("Strongly Agree"). The acceptability items include: "Overall, I was satisfied with the session" and "The presenters were effective in conveying the material". The appropriateness items include: "The session content was relevant to my clinical practice," "The session addressed challenges I face in my work with clients," and "The material was presented at an appropriate level of depth and complexity". A mean rating of 3.5/5 across sessions is used to operationalize acceptability and appropriateness. Feasibility will be evaluated based on attendance and homework completion rates which serve as markers for intervention engagement. The intervention was considered feasible if the majority of participants attend and complete at least 75% of the intervention and homework.

    Measured: Week 1 (after Session 1); Week 2 (after Session 2); Week 3 (after Session 3); Week 4 (after Session 4)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Aug 2025
  2. Study start1 Aug 2025
  3. Primary completion28 Nov 2025
  4. Study completion30 Sep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
Experimental: Alliance focused DBT training plus deliberate practice Active Control: Alliance focused DBT training plus reflective practice
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07119541
Sponsor's protocol ID
e2024-091
Status last verified
Jul 2026
First submitted
29 Jul 2025
Last updated
29 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Alliance-Focused Dialectical Behavior Therapy plus Deliberate Practice and Alliance-Focused Dialectical Behavior Therapy plus Reflective Practice in people with Borderline Personality Disorder and Emotion Dysregulation, run by York University at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 29 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Facilitative Interpersonal Skills Task (FIS) (time frame: Administered at baseline (pre-intervention) and at 4 weeks (post-intervention).). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jul 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in